Evidence to support this potential mechanism comes from research in mice (Roncal-Jimenez et al. 2017) and humans, with Mansour et al. (2019) observing that post-exercise copeptin (a stable surrogate for arginine vasopressin) concentrations were greater in marathon runners with AKI than those without AKI. Here, AVP is linked to acute kidney injury.